STEM CELL RESEARCH & THERAPY, cilt.7, 2016 (SCI-Expanded)
Background: This prospective clinical case series aimed to investigate the safety of subretinal adipose tissue-derived mesenchymal stem cell (ADMSC) implantation in advanced stage retinitis pigmentosa (RP).